Primaquine for Plasmodium vivax malaria treatment

Affiliations

¹ Department of Medicine, University of Melbourne, Melbourne, VIC 3021, Australia; Western Health Chronic Disease Alliance, Sunshine Hospital, Melbourne, VIC, Australia. Electronic address: harin.karunajeewa@wh.org.au.
² Division of Population Health and Immunity, The Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia.

Comment

Harin Karunajeewa et al. Lancet. 2020.

. 2020 Jun 27;395(10242):1971-1972.

doi: 10.1016/S0140-6736(20)30242-7.

¹ Department of Medicine, University of Melbourne, Melbourne, VIC 3021, Australia; Western Health Chronic Disease Alliance, Sunshine Hospital, Melbourne, VIC, Australia. Electronic address: harin.karunajeewa@wh.org.au.
² Division of Population Health and Immunity, The Walter and Eliza Hall Institute of Medical Research, Melbourne, VIC, Australia.

No abstract available

Comment in

Primaquine for Plasmodium vivax malaria treatment - Authors' reply.
Price RN, Taylor WRJ, Thriemer K, White NJ, Day NP. Price RN, et al. Lancet. 2020 Jun 27;395(10242):1972. doi: 10.1016/S0140-6736(20)30217-8. Lancet. 2020. PMID: 32593334 No abstract available.

Short-course primaquine for the radical cure of Plasmodium vivax malaria: a multicentre, randomised, placebo-controlled non-inferiority trial.
Taylor WRJ, Thriemer K, von Seidlein L, Yuentrakul P, Assawariyathipat T, Assefa A, Auburn S, Chand K, Chau NH, Cheah PY, Dong LT, Dhorda M, Degaga TS, Devine A, Ekawati LL, Fahmi F, Hailu A, Hasanzai MA, Hien TT, Khu H, Ley B, Lubell Y, Marfurt J, Mohammad H, Moore KA, Naddim MN, Pasaribu AP, Pasaribu S, Promnarate C, Rahim AG, Sirithiranont P, Solomon H, Sudoyo H, Sutanto I, Thanh NV, Tuyet-Trinh NT, Waithira N, Woyessa A, Yamin FY, Dondorp A, Simpson JA, Baird JK, White NJ, Day NP, Price RN. Taylor WRJ, et al. Lancet. 2019 Sep 14;394(10202):929-938. doi: 10.1016/S0140-6736(19)31285-1. Epub 2019 Jul 18. Lancet. 2019. PMID: 31327563 Free PMC article. Clinical Trial.